
In this concise video, the speaker provides an overview of rapamycin, emphasizing that it should not be used without medical supervision. He explains rapamycin’s established clinical role as an immunosuppressant for organ transplant patients, noting the daily dosing regimen and associated serious side effects. The talk then shifts to the longevity community’s off‑label practice of taking much smaller, once‑weekly doses, which some claim can “reboot” the body. The core of the explanation is the drug’s mechanism: rapamycin binds to and inhibits the mechanistic target of rapamycin (mTOR), a key regulator of cell growth, protein synthesis, metabolism, survival, and autophagy. By dampening mTOR activity, cells shift from an anabolic state toward autophagy‑driven cleanup and repair, a process likened to the cellular effects of intermittent fasting. The speaker cites a study showing that rapamycin extended the lifespan of rats, using this as experimental support for its potential longevity benefits, while reiterating the need for medical oversight.











